Combination chemotherapy with cisplatin and 5-fluorouracil 5-day infusion in the therapy of advanced gastric cancer: A Phase II trial
Ángel J. Lacave, F.J. Barón, L. M. Antón et al. · Annals of Oncology · 1991
Cited by 96 works. doi:10.1093/oxfordjournals.annonc.a057858
Authors
- Ángel J. Lacave
- L. M. Antón
- Enrique Estrada
- Luís Miguel de Sande
- Isabel Palacio
- Emilio Esteban
- J. Buesa
- O. Acosta Fernández
References
- Cancer: Principles and Practice of Oncology.
- Cancer of the stomach.
- A randomized trial of cisplatin (CACP) + 5-fluorouracil (5-FU) infusion and CACP + 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck
- 5 FU infusion with mitomycin-C vs. 5 FU infusion with methyl-CCNU in the treatment of advanced upper gastrointestinal cancer. A Southwest oncology group study
- High dose folinic acid/etoposide/5-fluorouracil in advanced gastric cancer — a phase II study in elderly patients or patients with cardiac risk
- Cisplatin.An active drug in the treatment of disseminated gastric cancer
- Continuous 5-Fluorouracil Infusion in Advanced Gastric Carcinoma
- Cisplatin in the treatment of advanced gastric carcinoma: a phase II study.
- Chemotherapy of advanced gastric cancer with 72‐hour continuous intravenous 5‐fluorouracil infusion at 2‐week intervals